Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025
Akero Therapeutics (NASDAQ: AKRO) presented new analyses of their Phase 2b HARMONY...
Akero Therapeutics (NASDAQ: AKRO) presented new analyses of their Phase 2b HARMONY...
The first round of oral arguments between Coinbase and U.S. regulators during their major legal war has come to a...
A United States appeals court is set to hear the oral arguments relating to Grayscale Investment’s lawsuit against the Securities...
Grayscale and the U.S. Securities and Exchange Commission will soon have their oral arguments heard in court regarding the conversion...
Grayscale filed a reply brief in its appeal of the United States Securities and Exchange Commission (SEC) denial of its...
In recent updates provided by James K. Filan, a Ripple ally and cryptocurrency start-up, LBRY, has requested that the court...